(Q39741862)

English

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

scientific article

Statements

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit